RNA-Seq Revealed Novel Non-proliferative Retinopathy Specific Circulating MiRNAs in T2DM Patients
- PMID: 31275351
- PMCID: PMC6593299
- DOI: 10.3389/fgene.2019.00531
RNA-Seq Revealed Novel Non-proliferative Retinopathy Specific Circulating MiRNAs in T2DM Patients
Abstract
Background: Diabetic retinopathy (DR) is a common diabetes complication and was considered as the major cause of blindness among young adults. MiRNAs are a group of small non-coding RNAs regulating the expression of target genes and have been reported to be associated with the development of DR in a variety of molecular mechanisms. In this study, we aimed to identify miRNAs that are differentially expressed (DE) in the serum of DR patients. Methods: We recruited 21 type 2 diabetes mellitus (T2DM) inpatients of Chinese Han ancestry, consisting of 10 non-proliferative DR patients (DR group) and 11 non-DR T2DM patients (NDR group). MiRNA was extracted from fasting peripheral serum and quantified by RNA-seq. The expression levels of miRNA were evaluated and compared between the two groups, with adjustments made for age differences. The validated target genes of miRNAs were subjected to a pathway analysis. We also constructed a weighted polygenic risk score using the DE miRNA and evaluated its predictive power. Results: Five miRNAs were DE between DR and NDR groups (p-Value ≤ 0.01, LFC ≥ 2 or LFC ≤-2). These included miR-4448, miR-338-3p, miR-190a-5p, miR-485-5p, and miR-9-5p. In total, these miRNAs were validated to regulate 55 target genes. Four target genes were found to overlap with the NAD metabolism, sirtuin, and aging pathway, which was thought to control the vascular growth and morphogenesis. The predictive power of our polygenic risk score was apparently high (AUC = 0.909). However, it needs to be interpreted with caution. Conclusion: In this study, we discovered novel DR-specific miRNAs in human serum samples. These circulating miRNAs may represent the pathological changes in the retina in response to diabetes and may serve as non-invasive biomarkers for early DR risk prediction.
Keywords: diabetes retinopathy; early prediction; microRNA; polygenic risk score; type 2 diabete mellitus.
Figures
Similar articles
-
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.Am J Physiol Endocrinol Metab. 2018 Sep 1;315(3):E374-E385. doi: 10.1152/ajpendo.00021.2018. Epub 2018 May 29. Am J Physiol Endocrinol Metab. 2018. PMID: 29812988
-
Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy.Clin Chim Acta. 2020 Feb;501:147-153. doi: 10.1016/j.cca.2019.10.036. Epub 2019 Oct 31. Clin Chim Acta. 2020. PMID: 31678272
-
Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy.Minerva Endocrinol (Torino). 2023 Mar;48(1):42-50. doi: 10.23736/S2724-6507.20.03278-2. Epub 2020 Nov 19. Minerva Endocrinol (Torino). 2023. PMID: 33213115
-
hsa-mir-(4328, 4422, 548z and -628-5p) in diabetic retinopathy: diagnosis, prediction and linking a new therapeutic target.Acta Diabetol. 2023 Jul;60(7):929-942. doi: 10.1007/s00592-023-02077-0. Epub 2023 Mar 31. Acta Diabetol. 2023. PMID: 37002321 Review.
-
MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics.Ann Transl Med. 2021 Aug;9(15):1280. doi: 10.21037/atm-20-5189. Ann Transl Med. 2021. PMID: 34532417 Free PMC article. Review.
Cited by
-
Advances in Research Related to MicroRNA for Diabetic Retinopathy.J Diabetes Res. 2024 Feb 12;2024:8520489. doi: 10.1155/2024/8520489. eCollection 2024. J Diabetes Res. 2024. PMID: 38375094 Free PMC article. Review.
-
Targeting ferroptosis: New perspectives of Chinese herbal medicine in the treatment of diabetes and its complications.Heliyon. 2023 Nov 11;9(12):e22250. doi: 10.1016/j.heliyon.2023.e22250. eCollection 2023 Dec. Heliyon. 2023. PMID: 38076182 Free PMC article. Review.
-
Complementary Approaches to Retinal Health Focusing on Diabetic Retinopathy.Cells. 2023 Nov 24;12(23):2699. doi: 10.3390/cells12232699. Cells. 2023. PMID: 38067127 Free PMC article. Review.
-
Research progress on the mechanism of ferroptosis and its role in diabetic retinopathy.Front Endocrinol (Lausanne). 2023 Jun 1;14:1155296. doi: 10.3389/fendo.2023.1155296. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37334304 Free PMC article. Review.
-
The regulatory role of microRNAs in common eye diseases: A brief review.Front Genet. 2023 Mar 29;14:1152110. doi: 10.3389/fgene.2023.1152110. eCollection 2023. Front Genet. 2023. PMID: 37065488 Free PMC article. Review.
References
-
- Benjamini Y., Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 57 289–300. 10.1111/j.2517-6161.1995.tb02031.x - DOI
LinkOut - more resources
Full Text Sources
